quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:08:53·532d
SECFiling
Axonics Inc. logo

SEC Form 10-Q filed by Axonics Inc.

AXNX· Axonics Inc.
Health Care
Original source

Companies

  • AXNX
    Axonics Inc.
    Health Care

Recent analyst ratings

  • Jan 9UpdateWolfe Research-
  • Jul 19UpdateRobert W. Baird$69.00
  • Jul 13UpdateKeyBanc Capital Markets$70.00
  • May 23UpdateCL King$75.00
  • Apr 14UpdateMizuho$75.00
  • Mar 24UpdateNeedham$71.00

Related

  • PR262d
    RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors
  • SEC514d
    SEC Form 15-12G filed by Axonics Inc.
  • SEC519d
    SEC Form EFFECT filed by Axonics Inc.
  • SEC524d
    SEC Form 25-NSE filed by Axonics Inc.
  • INSIDER524d
    Director Kiernan Jane E returned $1,410,131 worth of shares to the company (19,861 units at $71.00), closing all direct ownership in the company (SEC Form 4)
  • INSIDER524d
    EVP, Chief Mktg/Strtgy Officer Woock John returned $5,495,613 worth of shares to the company (77,403 units at $71.00), closing all direct ownership in the company (SEC Form 4)
  • INSIDER524d
    Director Snyderman Nancy Lynn Md returned $1,061,024 worth of shares to the company (14,944 units at $71.00), closing all direct ownership in the company (SEC Form 4)
  • INSIDER524d
    Chief Operating Officer Sama Rinda returned $5,996,802 worth of shares to the company (84,462 units at $71.00), closing all direct ownership in the company (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022